ITM and ANSTO Announce Extension of Licensing Agreement for the Production and Supply of the Medical Radioisotope n.c.a. Lutetium-177
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Activity Reference Time News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Activity Reference Time. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Activity Reference Time Today - Breaking & Trending Today
ITM Isotope Technologies Munich SE: ITM and ANSTO Announce Extension of Licensing Agreement for the Production and Supply of the Medical Radioisotope n.c.a. Lutetium-177
ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, and the Australian Nuclear Science and Technology Organisation (ANSTO), a public research organization and international
Source: finanznachrichten.de
Isotope Technologies Munich SE: ITM and Clovis Oncology Announce Lutetium-177 Clinical Supply Agreement
ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Clovis Oncology's Targeted Radionuclide Therapy candidate FAP-2286 ITM Isotope Technologies
Source: finanznachrichten.de
Clovis Oncology and ITM Announce Lutetium-177 Clinical Supply Agreement
Clovis Oncology, Inc. (NASDAQ: CLVS) and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, today announced the signing of a clinical supply agreement that provides
Source: sharewise.com